Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

MELOXICAM TABLETS

Awarded
SPE2DP26F6405Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded contract SPE2DP26F6405 to DMS Pharmaceutical Group Inc on June 6, 2026. This award is a delivery order issued under the primary contract SPE2DX25D9900 for the procurement of Meloxicam tablets, identified by national stock number 6505015413243. The contract was managed by the Department of Defense and posted via the DIBBS system. While the total contract price is specified within the award documentation, the agreement focuses on the supply of pharmaceutical goods to support federal agency requirements.

General Info

DMS Pharmaceutical Group Inc will supply Meloxicam tablets to the Defense Logistics Agency.

Agency

Department Of Defense → Defense Logistics AgencyView Agency

NAICS

424210 - Drugs and Druggists' Sundries Merchant WholesalersView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(3)

SPE2DP26F6405.pdf

PDF

SPE2DP26F6405_P00001.pdf

PDF

SPE2DP26F6405.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Organization / Agency
Department Of Defense → Defense Logistics Agency
View Agency Profile
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F6405 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: See Award Doc Award Date: 06-06-2026 Delivery order under: SPE2DX25D9900 Line items: - MELOXICAM TABLETS (NSN/Part 6505015413243)

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency